This spring, Cambridge Healthtech Institute (CHI) will host its ninth annual PEGS: The Essential Protein Engineering Summit at the Seaport World Trade Center in Boston, MA. Record attendance is expected in 2013. Its growth and success is attributable to the quality of scientific programming, expanded exhibit hall, and ample networking opportunities.
In addition to the new venue on Boston’s waterfront, the 2013 PEGS event now offers six programming streams and 16 conferences in protein and antibody engineering, oncology, expression, analytical, safety, and purification. The highly focused streams enable researchers to discuss and find solutions to challenges faced in their laboratories and hear about research that has yet to be published.Engineering Stream
Strategies and Tools for Creating the Next Generation of Biologics: Learn how the versatility of phage and yeast display — coupled with vast improvements in antibody engineering and production — are expanding possibilities for creating therapeutic entities and improving their success rates.Oncology Stream
Latest Trends for Future Best-in-Class Therapeutics: Delve into the current status of molecules in development. Discover strategies for ensuring the success of future protein therapeutics for oncology.Expression Stream
Meeting the Challenge to Improve Throughput and Quality: Discover new strategies for meeting the demand for large amounts of protein in a short time, fine-tuning expression systems, and improving throughput as well as the quality of expressed proteins.
Overcoming Challenges in Characterization, Biophysical Analysis, and Aggregation: Gain insight into the mechanisms and prevention of protein aggregation. Learn about strategies for achieving stability and solubility in biopharmaceutical products.Safety Stream
Strategies for Success in the Clinic and with Regulators: Develop a comprehensive immunogenicity and pharmacokinetics/pharmacodyamics (PK/PD) strategy. Become better able to manage challenges as they arise.Purification Stream
Purifying Protein While Ensuring Stability: Explore trends and technologies for processing active proteins and antibodies. Analyzing and predicting stability will also be investigated, with a goal of ensuring robust harvest of properly folded proteins.Keynote Plenary Session
A plenary keynote panel will convene to discuss the realistic outlook and uncertainties involved in developing a diverse array of noncanonical antibodies. Participants will discuss immunogenicity, safety, competition in the marketplace, commercial development, business strategies, regulatory approval, target validation, and clinical development.Special Events
Fourteen short courses will provide either a primer or in-depth workshop on topics ranging from phage and yeast display to immunogenicity and protein therapeutics.
Back by popular demand will be the biologics-focused “Partnering Forum” offered for both emerging companies with innovative technologies and established corporations seeking collaborations. The forum is designed to highlight promising early stage technologies and applications in antibody and protein engineering. Participants can listen to some three-dozen different companies in a single-track format. This forum also offers opportunities for scheduled and informal discussions with company presenters. The audience will include representatives from pharmaceutical, biotechnology, diagnostic, and other technology companies, as well as venture capitalists and other investors.Register, Sponsor, Exhibit
Year after year, PEGS challenges attendees to evolve their thinking around the generation, characterization, and clinical application of proteins. Join more than 1,200 of your colleagues this April in Boston to make your mark on the rapidly changing landscape of protein and antibody engineering.
For more information, visit PEGSummit.com. To learn about exhibit and sponsorship opportunities, contact Carol Dinerstein (director of business development) at 1-781-972-5471 or email@example.com.